Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …

The role of immunomodulatory agents in the treatment of hospitalized patients with COVID-19
has been of increasing interest. Anakinra, an interleukin-1 inhibitor, has been shown to …

Background: There is an increasing number of liver injury cases resembling autoimmune
hepatitis (AIH) following SARS-CoV-2 vaccination; however, an association has not yet been …

… Two-sided p values of <0.05 were considered statistically significant. Missing information …
(RC 0.01, 95% CI −0.0004, 0.02; p = 0.06) (these variables were examined in univariate meta-…

Superior vena cava syndrome (SVCS) is a clinical entity characterized by signs and symptoms
arising from the obstruction or occlusion of the thin-walled superior vena cava (SVC) and …

Simple Summary Takotsubo syndrome (TTS), also known as “broken heart” syndrome, is a
rare but serious heart event associated with physical or emotional stress. Patients usually …

Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer
compared with the general population. However, little is known on their immunization …

Background/Aim: Evidence suggests a beneficial effect of prone positioning (PP) in COVID-19.
Materials and Methods: Meta-analysis of individual (7 investigators’ groups) and …

Capecitabine is an oral 5-fluorouracil prodrug with antimetabolite activity commonly used in
advanced colorectal and breast cancer. It presents with a generally good toxicity profile and …